Table 2 Patient’s and donor’s characteristics in subgroups with and without DGF occurrence

Transplant variables

Donor’s age (years), mean ± SD

50.4 ± 13.8

51.8 ± 11

47.9 ± 17.7

0.355

CIT (hours), mean ± SD

18.8 ± 14 (median 18 (14–21)

21.2 ± 16.6

16.6 ± 4.4

0.200

2°WIT (minutes), mean ± SD

30.5 ± 12.7

32.7 ± 13.1

26.3 ± 10.9

0.074

SGF, n (%)

17 (23.3)

0

17 (56.7)

< 0.001

AR, n (%)

14 (19.1)

5 (11.6)

9 (30)

0.050

HLA mismatch in A, B, and DR, n (%)

1

1 (1.4)

1 (2.3)

0

0.958

2

5 (6.8)

4 (9.3)

1 (3.3)

0.643

3

27 (37)

15 (34.9)

12 (40)

0.656

4

34 (46.6)

23 (53.5)

11 (36.7)

0.156

5

1 (1.4)

0

1 (3.3)

0.855

Biochemical parameters at the end of the first posttransplant year

Hb (g/l), mean ± SD

129.7 ± 19.9

125.6 ± 16.6

137.2 ± 23.4

0.053

Leucocytes count, mean ± SD

6.8 ± 1.8

6.4 ± 1.5

7.5 ± 2

0.036

C-reactive protein (mg/l), median (IQR)

1.9 (0.6–5.8)

1.9 (0.55–8.55)

1 (0.7-4)

0.609

Glucose (mmol/l), mean ± SD

5.5 ± 0.9

5.4 ± 0.8

5.6 ± 1.1

0.387

Serum urea (mmol/l), mean ± SD

9.8 ± 4.9

10.9 ± 5.3

7.9 ± 3.5

0.028

Serum creatinine (µmol/l), mean ± SD

137.3 ± 50.4

146.1 ± 54.5

124.2 ± 41.2

0.087

Serum albumin (mmol/l), mean ± SD

44.1 ± 3.6

43.9 ± 3.9

44.4 ± 3.2

0.673

Serum uric acid (mmol/l), mean ± SD

399 ± 75.9

416.4 ± 82.1

368.5 ± 52.4

0.019

Alkaline phosphatase (IU/l), mean ± SD

81.8 ± 36.8

86.7 ± 39.8

71.5 ± 28

0.193

Proteinuria (g/24 h), mean ± SD

0.3 ± 0.22

0.3 ± 0.25

0.22 ± 0.21

0.260

Infections during the first posttransplant year

Positive PCR BKV in blood, n (%)

15 (20.5)

9 (20.9)

6 (20)

0.923

PCR CMV in blood, n (%)

9 (12.3)

6 (14)

3 (10)

0.613

Positive IgM VZV, n (%)

5 (6.8)

4 (9.3)

1 (3.3)

0.643

Donor’s characteristics

KPDI (%)

53.8 ± 28.6

55 ± 27.3

49.9 ± 34.7

0.664

BMI (kg/m²)

25.2 ± 2.6

25.4 ± 2.6

24.6 ± 2.8

0.477

Donor’s HTN (N = 60)

60

13/38 (34.2%)

6/22 (27.3%)

0.578

Donor’s DM

0

0

0

/